We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Laboratory Medicine and Nosocomial Infections: the Present

By LabMedica International staff writers
Posted on 17 Feb 2010
Nosocomial infections or hospital acquired infections (HAIs) are generally diagnosed between 2 to 4 days after a patient is admitted to a hospital, as the patient develops a fever that is not explained by an underlying illness. More...
In elderly patients, the first signs of infection may be rapid breathing or mental confusion.

Organisms responsible for nosocomial or hospital acquired infections (HAIs) need to be identified by the clinical laboratory as quickly as possible. This enables hospital staff to treat and isolate infected patients, choose appropriate treatment, and prevent overuse of antibiotics.

Laboratory tests are conducted including complete blood counts (CBCs), especially to look for an increase in infection-fighting white blood cells (WBCs); urinalysis, to search for white cells or evidence of blood in the urinary tract; cultures of the infected area, blood, sputum, urine, or other body fluids or tissue to find the causative organism. The laboratory also reviews all procedures performed that might have led to infection.

The organisms are retested for antibiotic sensitivity so that the patient can be treated quickly and effectively. Many bacteria have become resistant to standard antibiotic treatments, especially when patients with chronic illnesses are given antibiotic therapy for long periods. If this happens, the patient is treated with a more specific antibiotic to which the organism is sensitive.

The newest tests will facilitate earlier and more appropriate antibiotic treatment of patients. They should also lead to earlier implementation of infection control interventions that help prevent the transmission of the pathogens to other patients.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.